ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
PainReform Ltd

PainReform Ltd (PRFX)

0.583
-0.0371
(-5.98%)
Closed 13 October 7:00AM
0.5653
-0.0177
(-3.04%)
After Hours: 10:39AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.5653
Bid
0.5612
Offer
0.614
Volume
156,824
0.5311 Day's Range 0.605
0.5653 52 Week Range 20.16
Market Cap
Previous Close
0.6201
Open
0.60
Last Trade Time
Financial Volume
US$ 91,684
VWAP
0.584627
Average Volume (3m)
1,381,088
Shares Outstanding
1,171,041
Dividend Yield
-
PE Ratio
-0.07
Earnings Per Share (EPS)
-7.98
Revenue
-
Net Profit
-9.34M

About PainReform Ltd

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Herzliya, Center, Isr
Founded
-
PainReform Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRFX. The last closing price for PainReform was US$0.62. Over the last year, PainReform shares have traded in a share price range of US$ 0.5653 to US$ 20.16.

PainReform currently has 1,171,041 shares in issue. The market capitalisation of PainReform is US$726,162.52 . PainReform has a price to earnings ratio (PE ratio) of -0.07.

PRFX Latest News

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

TEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the...

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

TEL AVIV, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0457-7.479541734860.6110.6952990.5653514310.64529016CS
4-0.2746-32.69436837720.83991.030.56533866090.78825761CS
12-2.6669-82.51036445763.23223.360.565313810881.4944624CS
26-7.3547-92.86237373747.928.640.56537249551.76802927CS
52-17.4347-96.85944444441820.160.56534008792.57117272CS
156-154.8347-99.6362290862155.4169.20.565333225443.05851021CS
260-399.6347-99.8587456272400.2470.40.5653381577111.57945394CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAMPCAMP4 Therapeutics Corporation
 10.75
(2,587.50%)
378.47k
TWGTop Wealth Group Holding Ltd
US$ 7.14
(233.64%)
154.23M
NIVFNewGenIvf Group Ltd
US$ 0.98
(63.42%)
58.51M
ATIFATIF Holdings Ltd
US$ 1.235
(58.33%)
3.85M
VERBVerb Technology Company Inc
US$ 7.91
(51.82%)
15.55M
BYUBAIYU Holdings Inc
US$ 0.299
(-35.28%)
11.11M
TURBTurbo Energy SA
US$ 2.1511
(-29.01%)
3.2M
SMSTDefiance Daily Target 1.5X Short MSTR ETF
US$ 7.898
(-23.62%)
993.33k
VEEAVeea Inc
US$ 3.27
(-23.24%)
284.95k
INHDInno Holdings Inc
US$ 3.74
(-22.41%)
257.75k
JTAIJet AI Inc
US$ 0.1009
(23.50%)
340.09M
CDTConduit Pharmaceuticals Inc
US$ 0.116
(13.28%)
270.97M
NVDANVIDIA Corporation
US$ 134.80
(-0.01%)
170.27M
LUXHLuxUrban Hotels Inc
US$ 0.0532
(5.35%)
165.94M
TWGTop Wealth Group Holding Ltd
US$ 7.14
(233.64%)
154.23M

PRFX Discussion

View Posts
Monksdream Monksdream 3 weeks ago
PRFX new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 3 weeks ago
PRFX new 52 week low
πŸ‘οΈ0
tw0122 tw0122 3 weeks ago
New reoffering couldn’t sell shares first time nor on new reduced price take it to
20 cents and do another reverse split. Bye bye shareholders this is the penny bio scam game
πŸ‘οΈ0
Awl416 Awl416 3 weeks ago
Wouldnt*
πŸ‘οΈ0
Awl416 Awl416 3 weeks ago
I would fall for it
πŸ‘οΈ0
Surfacetite Surfacetite 1 month ago
Snagged some. Good pr
πŸ‘οΈ0
Awl416 Awl416 1 month ago
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
πŸ‘οΈ0
glenn1919 glenn1919 1 month ago
PRFX...............................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Awl416 Awl416 1 month ago
That chart. Yikes…
πŸ‘οΈ0
it_happens it_happens 2 months ago
Moving up nicely today
πŸ‘οΈ0
it_happens it_happens 2 months ago
Doesn't look like it today
πŸ‘οΈ0
Surfacetite Surfacetite 2 months ago
Can we break $1 again.
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 months ago
its much better to trade the front side of these runs, than trying to catch a dip and rip

otherwise you can get caught in one of these all day chop & grind, lower lows, Gap & Traps like PRFX

Ive learned too many le$$ons the hard way
πŸ‘οΈ0
Tool_power Tool_power 2 months ago
.25
πŸ‘οΈ0
stock1ace1 stock1ace1 2 months ago
.30
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 months ago
PRFX: Hey, Bro, the ONLY "PainReform" this Israel company must engage is the termination of the Hitler-like SLAUGHTER of patently-innocent Arabic kids, adults, seniors, & their pet cats & dogs.
πŸ‘οΈ0
Tool_power Tool_power 2 months ago
Catching a bid @ .33
πŸ‘οΈ0
madras50 madras50 2 months ago
i 2nd that
πŸ‘οΈ0
Awl416 Awl416 2 months ago
YIKES
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 months ago
ouch~! 35z
πŸ‘οΈ0
glenn1919 glenn1919 2 months ago
PRFX.................................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 months ago
PRFX: Its ISRAEL headquarters ruined this!!! (FUCK that damn nation!!)
πŸ‘οΈ0
tw0122 tw0122 2 months ago
Printing dilution shares faster then the Federal Reserve prints cash . They are Gangsta
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
incoming attack from enemy drones....
πŸ‘οΈ0
it_happens it_happens 2 months ago
Kind of like a yoyo this morning. Think it will go back up?
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 months ago
TOOK SOME .59'S HPW BOUT U
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
dilution up...cash down...warrants and s-1s galore~!
πŸ‘οΈ0
tw0122 tw0122 2 months ago
Crash landing
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
ouch...dilution brings it down fast
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 months ago
1.17 -.64 IS RUDE
πŸ‘οΈ0
Awl416 Awl416 2 months ago
That was rude
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 months ago
$1 🤑BREAK
πŸ‘οΈ0
tw0122 tw0122 2 months ago
Join the hedgies lol .95 + 200%
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 months ago
https://healthstockshub.com/news/nyseamex/igc/igc-pharma-expands-drug-portfolio-to-metabolic-disorders-with-igc-1a-a-potential-new-glp-1-agonist

https://dilutiontracker.com/app/search/PRFX?a=dbb88c
πŸ‘οΈ0
Awl416 Awl416 2 months ago
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
PRFX new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
PRFX new 52 week low
πŸ‘οΈ0
FALCON1 FALCON1 3 months ago
https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
πŸ‘οΈ0
Sirpeter Sirpeter 3 months ago
I'm out again...was too early...it will have its day by Y/E
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
PRFX new 52 week low
πŸ‘οΈ0
Tool_power Tool_power 3 months ago
What the heck is happening here? Capitulation? Ex-CEO Hadar dumping?

Or, in a best case scenario MMs are looking for inventory before a run. Dip and rip is common. Time will tell.
πŸ‘οΈ0
Sirpeter Sirpeter 3 months ago
... heading for the promised land...just starting
πŸ‘οΈ0
Sirpeter Sirpeter 3 months ago
...all I know is this is way oversold and the product seems to be working...to be honest Im here for a quick trade...I make the big money playing options
πŸ‘οΈ0
Tool_power Tool_power 3 months ago
We should get a bump, especially if the promising results in April are confirmed (96 hr pain relief Vs. 72 hr, and better performance than the leading competitor product).

But Hadar was saying that after these clinical trials for Bunionectomy (hard tissue) were concluded that they would then do the Hernia operation (soft tissue) clinical trials in 2025 with planned NDA submission in 2026. I wonder if that strategy will change now?
πŸ‘οΈ0
Sirpeter Sirpeter 3 months ago
Dont know...doesnt matter as long as the last phase of the drug trial is happening...we should get a bump soon
πŸ‘οΈ0
Tool_power Tool_power 3 months ago
Interesting that CEO Hadar stepped down. I have no problem with this as I didn’t think he was very good, but I wonder why he made this decision.

I have more confidence in Dr. Ehud Geller as the interim.
πŸ‘οΈ0
Sirpeter Sirpeter 3 months ago
Added some today...low enough...dont see any danger of RS...will be past $1 soon enough
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
PRFX new 52 week low
πŸ‘οΈ0
Sirpeter Sirpeter 4 months ago
Think we have to wait for more news on this one...need to know whwn drug trial ends...maybe around Sept
πŸ‘οΈ0
Tiger Money Tiger Money 4 months ago
Taking off a little bit now
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock